A comparison of peginterferon alfa-2a plus ribavirin and peginterferon alfa-2b plus ribavirin for. postmenopausal women. with chronic hepatitis type C : An open-label randomized controlled trial.

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2008
INTERVENTION: PegIFN‐alpha2a plus ribavirin PegIFN‐alpha2b plus ribavirin CONDITION: Chronic hepatitis C PRIMARY OUTCOME: virologic response at 12 weeks SECONDARY OUTCOME: Sustained virologic response; Safety ( moniterd clinical and laboratory evaluation) INCLUSION CRITERIA: 1) Naive case 2) genotype 1 and high pretreatment viremia 3) postmenopausal women
Epistemonikos ID: 2c3caca6b99672ae185af0a86d99e4fd8262805e
First added on: Aug 21, 2024